Related Experiment Video
Updated: May 30, 2026
04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
Thyroid autoantibodies and pregnancy outcomes
1mina_abbassi2003@yahoo.com
Clinical Obstetrics and Gynecology
|August 23, 2011
Summary
Thyroid antibodies in pregnancy are linked to miscarriage and placental abruption. However, treating autoimmune thyroid disease in euthyroid pregnant women is not recommended due to insufficient evidence of benefit.
Area of Science:
- Reproductive Endocrinology
- Immunology
- Obstetrics
Background:
- Autoimmune thyroid disease is linked to adverse pregnancy outcomes like miscarriage and placental abruption.
- The role of thyroid antibodies in recurrent pregnancy loss and preterm birth remains unclear.
- Evidence supporting intervention for autoimmune thyroid disease in euthyroid pregnant women is limited.
Purpose of the Study:
- To evaluate the association between thyroid antibodies and adverse pregnancy outcomes.
- To assess the potential benefits of treating autoimmune thyroid disease in euthyroid pregnant women.
Main Methods:
- Review of existing studies on thyroid antibodies and pregnancy outcomes.
- Analysis of data regarding intervention effects in euthyroid pregnant women with autoimmune thyroid disease.
Main Results:
- Confirmed association between thyroid antibodies and increased risk of spontaneous miscarriage and placental abruption.
- Conflicting and statistically non-significant data regarding thyroid antibodies and recurrent pregnancy loss or preterm birth in large studies.
- Insufficient evidence on the benefits of treating autoimmune thyroid disease in euthyroid pregnant women.
Conclusions:
- Routine screening and treatment for autoimmune thyroid disease in euthyroid pregnant women are not currently recommended.
- Further research is needed to clarify the impact of thyroid antibodies on specific pregnancy complications.
- Clinical guidelines should reflect the current lack of evidence for routine intervention.
Related Concept Videos
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...